Regulatory Focus™ > News Articles > Regulatory Process Enhancements Can Reduce Risk for Device Manufacturers Using Local Agents

Regulatory Process Enhancements Can Reduce Risk for Device Manufacturers Using Local Agents

Posted 01 April 2011 | By

US-based manufacturers working with local agents to register medical devices outside the US (OUS) are at risk of legal action if they do not have a method to verify that the documentation submitted by the agent accurately represents the product that the manufacturer intends to sell in the given market.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe